![\"An](\"https:\/\/d.medicaldaily.com\/en\/full\/267189\/pills.jpg?w=466&h=311&f=657317815b9e5c5d57b101235e54cc93\")
<\/a><\/figure>Therapy-Resistant Hepatitis C Infections Cured In 3 Months With New, Injection-Free Drug Combination<\/a><\/h3>An injection-free drug combination was shown to cure hepatitis C in 98 percent of participants in a clinical trial.<\/summary><\/li>![\"Coffee](\"https:\/\/d.medicaldaily.com\/en\/full\/265154\/coffee-cigarette.jpg?w=466&h=311&f=546308a1fbe280f9f86f9518c587181b\")
<\/a><\/figure>Smokers And Coffee Drinkers 'Protected' Against Liver Disease, May Have Lower Risk Of Primary Sclerosing Cholangitis<\/a><\/h3>Coffee and cigarettes may lower your risk of developing the rare liver disease primary sclerosing cholangitis.<\/summary><\/li>![\"David](\"https:\/\/d.medicaldaily.com\/en\/full\/264142\/david-matthew-kwiatkowski.jpg?w=466&h=311&f=9d99b1d3cafa93eeaa734f23f59d526f\")
<\/a><\/figure>David Kwiatkowski, Hospital Tech Who Infected Patients With Hepatitis C, Faces Up To 40 Years In Federal Prison<\/a><\/h3>David Kwiatkowski, a traveling hospital technician who infected at least 32 people with hepatitis C using syringes tainted with his own infected blood, will receive his sentence on Monday.<\/summary><\/li>![\"Blocking](\"https:\/\/d.medicaldaily.com\/en\/full\/262070\/cancerous-cells.jpg?w=466&h=311&f=a8be19e846a6c51e18121939fc0f5753\")
<\/a><\/figure>New Drug Combination Causes Cancer To 'Eat' Itself, Could Soon Treat Multiple Cancer Types<\/a><\/h3>A new combination of enzyme inhibiting drugs that causes cancerous cells to digest themselves could soon enter clinical trials.<\/summary><\/li>![\"Since](\"https:\/\/d.medicaldaily.com\/en\/full\/260102\/hair.jpg?w=466&h=311&f=3fdf530560e3cbca76081cd82a7552aa\")
<\/a><\/figure>Americans Sell Hair, Eggs, And More, Amid Sluggish Financial Recovery<\/a><\/h3>Lingering effects of the recession are prompting Americans to turn to their own bodies for economic security.<\/summary><\/li>![\"Four](\"https:\/\/d.medicaldaily.com\/en\/full\/252391\/clone-cup-coffee.jpg?w=466&h=311&f=da887bc3c7c5e0a42ec092d7f5e8f4bc\")
<\/a><\/figure>Caffeine Could Be Good For Your Liver: Coffee And Tea Study Shows How The Chemical Can Reduce Fatty Liver<\/a><\/h3>Four cups of coffee or tea can prevent and protect against non-alcoholic fatty liver disorder.<\/summary><\/li>![\"Image\"](\"https:\/\/d.medicaldaily.com\/en\/full\/221288\/saffron-spice-bala.jpg?w=466&h=311&l=50&t=30&f=2e1f2051bc91a5a448ff4a06cd427bab\")
<\/a><\/figure>Saffron Can Help Prevent Liver Cancer<\/a><\/h3>Saffron have been found to promote apoptosis a regulated form of cell death and inhibit growth of cancerous cells in animal models.<\/summary><\/li>Obesity May Accelerate the Progression of Cirrhosis<\/a><\/h3>Increased Body Mass Index (BMI) is an independent predictor of clinical decompensation in patients with compensated cirrhosis<\/summary><\/li>Noninvasive liver tests may predict hepatitis C patient survival<\/a><\/h3>Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.<\/summary><\/li>Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis<\/a><\/h3>Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.<\/summary><\/li>"}
<\/a><\/figure>Smokers And Coffee Drinkers 'Protected' Against Liver Disease, May Have Lower Risk Of Primary Sclerosing Cholangitis<\/a><\/h3>Coffee and cigarettes may lower your risk of developing the rare liver disease primary sclerosing cholangitis.<\/summary><\/li><\/a><\/figure>David Kwiatkowski, Hospital Tech Who Infected Patients With Hepatitis C, Faces Up To 40 Years In Federal Prison<\/a><\/h3>David Kwiatkowski, a traveling hospital technician who infected at least 32 people with hepatitis C using syringes tainted with his own infected blood, will receive his sentence on Monday.<\/summary><\/li><\/a><\/figure>New Drug Combination Causes Cancer To 'Eat' Itself, Could Soon Treat Multiple Cancer Types<\/a><\/h3>A new combination of enzyme inhibiting drugs that causes cancerous cells to digest themselves could soon enter clinical trials.<\/summary><\/li><\/a><\/figure>Americans Sell Hair, Eggs, And More, Amid Sluggish Financial Recovery<\/a><\/h3>Lingering effects of the recession are prompting Americans to turn to their own bodies for economic security.<\/summary><\/li><\/a><\/figure>Caffeine Could Be Good For Your Liver: Coffee And Tea Study Shows How The Chemical Can Reduce Fatty Liver<\/a><\/h3>Four cups of coffee or tea can prevent and protect against non-alcoholic fatty liver disorder.<\/summary><\/li><\/a><\/figure>Saffron Can Help Prevent Liver Cancer<\/a><\/h3>Saffron have been found to promote apoptosis a regulated form of cell death and inhibit growth of cancerous cells in animal models.<\/summary><\/li>Obesity May Accelerate the Progression of Cirrhosis<\/a><\/h3>Increased Body Mass Index (BMI) is an independent predictor of clinical decompensation in patients with compensated cirrhosis<\/summary><\/li>Noninvasive liver tests may predict hepatitis C patient survival<\/a><\/h3>Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.<\/summary><\/li>Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis<\/a><\/h3>Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.<\/summary><\/li>"}
<\/a><\/figure>David Kwiatkowski, Hospital Tech Who Infected Patients With Hepatitis C, Faces Up To 40 Years In Federal Prison<\/a><\/h3>David Kwiatkowski, a traveling hospital technician who infected at least 32 people with hepatitis C using syringes tainted with his own infected blood, will receive his sentence on Monday.<\/summary><\/li><\/a><\/figure>New Drug Combination Causes Cancer To 'Eat' Itself, Could Soon Treat Multiple Cancer Types<\/a><\/h3>A new combination of enzyme inhibiting drugs that causes cancerous cells to digest themselves could soon enter clinical trials.<\/summary><\/li><\/a><\/figure>Americans Sell Hair, Eggs, And More, Amid Sluggish Financial Recovery<\/a><\/h3>Lingering effects of the recession are prompting Americans to turn to their own bodies for economic security.<\/summary><\/li><\/a><\/figure>Caffeine Could Be Good For Your Liver: Coffee And Tea Study Shows How The Chemical Can Reduce Fatty Liver<\/a><\/h3>Four cups of coffee or tea can prevent and protect against non-alcoholic fatty liver disorder.<\/summary><\/li><\/a><\/figure>Saffron Can Help Prevent Liver Cancer<\/a><\/h3>Saffron have been found to promote apoptosis a regulated form of cell death and inhibit growth of cancerous cells in animal models.<\/summary><\/li>Obesity May Accelerate the Progression of Cirrhosis<\/a><\/h3>Increased Body Mass Index (BMI) is an independent predictor of clinical decompensation in patients with compensated cirrhosis<\/summary><\/li>Noninvasive liver tests may predict hepatitis C patient survival<\/a><\/h3>Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.<\/summary><\/li>Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis<\/a><\/h3>Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.<\/summary><\/li>"}
<\/a><\/figure>New Drug Combination Causes Cancer To 'Eat' Itself, Could Soon Treat Multiple Cancer Types<\/a><\/h3>A new combination of enzyme inhibiting drugs that causes cancerous cells to digest themselves could soon enter clinical trials.<\/summary><\/li><\/a><\/figure>Americans Sell Hair, Eggs, And More, Amid Sluggish Financial Recovery<\/a><\/h3>Lingering effects of the recession are prompting Americans to turn to their own bodies for economic security.<\/summary><\/li><\/a><\/figure>Caffeine Could Be Good For Your Liver: Coffee And Tea Study Shows How The Chemical Can Reduce Fatty Liver<\/a><\/h3>Four cups of coffee or tea can prevent and protect against non-alcoholic fatty liver disorder.<\/summary><\/li><\/a><\/figure>Saffron Can Help Prevent Liver Cancer<\/a><\/h3>Saffron have been found to promote apoptosis a regulated form of cell death and inhibit growth of cancerous cells in animal models.<\/summary><\/li>Obesity May Accelerate the Progression of Cirrhosis<\/a><\/h3>Increased Body Mass Index (BMI) is an independent predictor of clinical decompensation in patients with compensated cirrhosis<\/summary><\/li>Noninvasive liver tests may predict hepatitis C patient survival<\/a><\/h3>Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.<\/summary><\/li>Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis<\/a><\/h3>Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.<\/summary><\/li>"}
<\/a><\/figure>Americans Sell Hair, Eggs, And More, Amid Sluggish Financial Recovery<\/a><\/h3>Lingering effects of the recession are prompting Americans to turn to their own bodies for economic security.<\/summary><\/li><\/a><\/figure>Caffeine Could Be Good For Your Liver: Coffee And Tea Study Shows How The Chemical Can Reduce Fatty Liver<\/a><\/h3>Four cups of coffee or tea can prevent and protect against non-alcoholic fatty liver disorder.<\/summary><\/li><\/a><\/figure>Saffron Can Help Prevent Liver Cancer<\/a><\/h3>Saffron have been found to promote apoptosis a regulated form of cell death and inhibit growth of cancerous cells in animal models.<\/summary><\/li>Obesity May Accelerate the Progression of Cirrhosis<\/a><\/h3>Increased Body Mass Index (BMI) is an independent predictor of clinical decompensation in patients with compensated cirrhosis<\/summary><\/li>Noninvasive liver tests may predict hepatitis C patient survival<\/a><\/h3>Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.<\/summary><\/li>Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis<\/a><\/h3>Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.<\/summary><\/li>"}
<\/a><\/figure>Caffeine Could Be Good For Your Liver: Coffee And Tea Study Shows How The Chemical Can Reduce Fatty Liver<\/a><\/h3>Four cups of coffee or tea can prevent and protect against non-alcoholic fatty liver disorder.<\/summary><\/li><\/a><\/figure>Saffron Can Help Prevent Liver Cancer<\/a><\/h3>Saffron have been found to promote apoptosis a regulated form of cell death and inhibit growth of cancerous cells in animal models.<\/summary><\/li>Obesity May Accelerate the Progression of Cirrhosis<\/a><\/h3>Increased Body Mass Index (BMI) is an independent predictor of clinical decompensation in patients with compensated cirrhosis<\/summary><\/li>Noninvasive liver tests may predict hepatitis C patient survival<\/a><\/h3>Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.<\/summary><\/li>Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis<\/a><\/h3>Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.<\/summary><\/li>"}
<\/a><\/figure>